Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-derived Von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial

NCT01064284 is registered in ClinicalTrials.gov with Fondazione Angelo Bianchi Bonomi as lead sponsor.

NCT NCT01064284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01064284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-derived Von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial
Lead sponsor
Fondazione Angelo Bianchi Bonomi
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
May 31, 2015
Enrollment
303 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a